Effects of rosuvastatin on serum glucose and insulin in hyperuricemic rats. 2022

Dilidaer Xilifu, and Zumulaiti Tuerxun, and Buweiayixiemu Nuermaimaiti, and Ayinu Aili, and Nijiati Rehemu, and Huiping Sun, and Xiangyang Zhang
Department of CardiologyCardiac care unit, Department of Cardiology, The First Affiliated Hospital of Xinjiang Medical University, 137 Xinyiroad, Xinshi District, ÜrÜmqi, Xinjiang, 830011, P.R. China.

Hyperuricemia is a state in which the serum levels of uric acid (UA) are elevated. This study was to determine the roles of rosuvastatin in fasting blood glucose (FGB) and insulin levels in hyperuricemic rats. Thirty-six Sprague-Dawley (SD) rats were randomized divided into the control, model and rosuvastatin groups: the control was given no intervention, the model group was established by administrating yeast extract powder and oxonic acid potassium salt, and the rosuvastatin group was given intravenous administration of rosuvastatin for 28 days in hyperuricemic rats. Serum uric acid (SUA), fasting blood glucose (FBG), fasting blood insulin (FBI), glutamic acid decarboxylase antibody (GADA), oral glucose tolerance test (OGTT) levels, and the ultrastructure of pancreatic β-cells were measured. Also, homeostasis model assessment of insulin resistance (HOMA-IR) scores was computed in three groups. Compared to the model group, SUA were decreased, while the FBG, GADA, OGTT and HOMA-IR at week 4 were significantly increased in rosuvastatin group. However, FBI was not significantly changed between three groups. It was also showed that the structure of pancreatic β-cells was damaged and the number of β-cells was changed in hyperuricemic rats while they were aggravated in rosuvastatin group. Rosuvastatin has roles in inducing FGB, GADA, OGTT and pancreatic β-cells damage in hyperuricemic rats.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D000068718 Rosuvastatin Calcium A HYDROXYMETHYLGLUTARYL-COA-REDUCTASE INHIBITOR, or statin, that reduces the plasma concentrations of LDL-CHOLESTEROL; APOLIPOPROTEIN B, and TRIGLYCERIDES while increasing HDL-CHOLESTEROL levels in patients with HYPERCHOLESTEROLEMIA and those at risk for CARDIOVASCULAR DISEASES. Crestor,Rosuvastatin,ZD 4522,ZD4522,Calcium, Rosuvastatin
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014527 Uric Acid An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN. 2,6,8-Trihydroxypurine,Ammonium Acid Urate,Monosodium Urate,Monosodium Urate Monohydrate,Potassium Urate,Sodium Acid Urate,Sodium Acid Urate Monohydrate,Sodium Urate,Sodium Urate Monohydrate,Trioxopurine,Urate,Acid Urate, Ammonium,Acid Urate, Sodium,Acid, Uric,Monohydrate, Monosodium Urate,Monohydrate, Sodium Urate,Urate Monohydrate, Monosodium,Urate Monohydrate, Sodium,Urate, Ammonium Acid,Urate, Monosodium,Urate, Potassium,Urate, Sodium,Urate, Sodium Acid
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D033461 Hyperuricemia Excessive URIC ACID or urate in blood as defined by its solubility in plasma at 37 degrees C; greater than 0.42mmol per liter (7.0mg/dL) in men or 0.36mmol per liter (6.0mg/dL) in women. This condition is caused by overproduction of uric acid or impaired renal clearance. Hyperuricemia can be acquired, drug-induced or genetically determined (LESCH-NYHAN SYNDROME). It is associated with HYPERTENSION and GOUT.

Related Publications

Dilidaer Xilifu, and Zumulaiti Tuerxun, and Buweiayixiemu Nuermaimaiti, and Ayinu Aili, and Nijiati Rehemu, and Huiping Sun, and Xiangyang Zhang
December 2014, Experimental and therapeutic medicine,
Dilidaer Xilifu, and Zumulaiti Tuerxun, and Buweiayixiemu Nuermaimaiti, and Ayinu Aili, and Nijiati Rehemu, and Huiping Sun, and Xiangyang Zhang
October 1996, Transplantation proceedings,
Dilidaer Xilifu, and Zumulaiti Tuerxun, and Buweiayixiemu Nuermaimaiti, and Ayinu Aili, and Nijiati Rehemu, and Huiping Sun, and Xiangyang Zhang
April 2002, Wei sheng yan jiu = Journal of hygiene research,
Dilidaer Xilifu, and Zumulaiti Tuerxun, and Buweiayixiemu Nuermaimaiti, and Ayinu Aili, and Nijiati Rehemu, and Huiping Sun, and Xiangyang Zhang
January 1971, Texas reports on biology and medicine,
Dilidaer Xilifu, and Zumulaiti Tuerxun, and Buweiayixiemu Nuermaimaiti, and Ayinu Aili, and Nijiati Rehemu, and Huiping Sun, and Xiangyang Zhang
August 1992, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
Dilidaer Xilifu, and Zumulaiti Tuerxun, and Buweiayixiemu Nuermaimaiti, and Ayinu Aili, and Nijiati Rehemu, and Huiping Sun, and Xiangyang Zhang
October 1977, Chemical & pharmaceutical bulletin,
Dilidaer Xilifu, and Zumulaiti Tuerxun, and Buweiayixiemu Nuermaimaiti, and Ayinu Aili, and Nijiati Rehemu, and Huiping Sun, and Xiangyang Zhang
January 2012, BioImpacts : BI,
Dilidaer Xilifu, and Zumulaiti Tuerxun, and Buweiayixiemu Nuermaimaiti, and Ayinu Aili, and Nijiati Rehemu, and Huiping Sun, and Xiangyang Zhang
April 1980, Medical biology,
Dilidaer Xilifu, and Zumulaiti Tuerxun, and Buweiayixiemu Nuermaimaiti, and Ayinu Aili, and Nijiati Rehemu, and Huiping Sun, and Xiangyang Zhang
January 2000, Indian journal of physiology and pharmacology,
Dilidaer Xilifu, and Zumulaiti Tuerxun, and Buweiayixiemu Nuermaimaiti, and Ayinu Aili, and Nijiati Rehemu, and Huiping Sun, and Xiangyang Zhang
August 1971, The American journal of physiology,
Copied contents to your clipboard!